dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted HGF and MET: From Brain Development to Neurological Disorders PMC Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Activated HGF c Met Axis in Head and Neck Cancer
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22


